Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.

MLA

Liu, Chia-Wen, et al. “Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.” Molecular Cancer Therapeutics, vol. 16, no. 7, July 2017, pp. 1421–34. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-16-0567-T.

APA

Liu, C.-W., Hua, K.-T., Li, K.-C., Kao, H.-F., Hong, R.-L., Ko, J.-Y., Hsiao, M., Kuo, M.-L., & Tan, C.-T. (2017). Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics, 16(7), 1421–1434. https://doi.org/10.1158/1535-7163.MCT-16-0567-T

Chicago

Liu, Chia-Wen, Kuo-Tai Hua, Kai-Chun Li, Hsiang-Fong Kao, Ruey-Long Hong, Jenq-Yuh Ko, Michael Hsiao, Min-Liang Kuo, and Ching-Ting Tan. 2017. “Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.” Molecular Cancer Therapeutics 16 (7): 1421–34. doi:10.1158/1535-7163.MCT-16-0567-T.